Introduction to the newborn screening fact sheets

Pediatrics

Volumn 118, Issue 3, 2006, Pages 1304-1312

  Kaye, Celia I ^a   Schaefer, G Bradley ^a   Bull, Marilyn J ^a   Enns, Gregory M ^a   Gruen, Jeffrey R ^a   Hersh, Joseph H ^a   Mendelsohn, Nancy J ^a   Saal, Howard M ^a  

^a AAP Committee on Genetics ^*

Author keywords

Biotinidase deficiency; Congenital adrenal hyperplasia; Congenital hearing loss; Congenital hypothyroidism; Cystic fibrosis; Galactosemia; Genetic disorder; Hemoglobinopathies; Homocystinuria; Maple syrup urine disease; Newborn screening; Screening

Indexed keywords

BIOTINIDASE DEFICIENCY; CHILD HEALTH CARE; CONGENITAL ADRENAL HYPERPLASIA; CONGENITAL DEAFNESS; CONGENITAL HYPOTHYROIDISM; CYSTIC FIBROSIS; DIAGNOSTIC TEST; DNA DETERMINATION; ENZYME DEFICIENCY; FOLLOW UP; GALACTOSEMIA; GENETIC COUNSELING; HEALTH CARE PERSONNEL; HEALTH CARE SYSTEM; HEMOGLOBINOPATHY; HOMOCYSTINURIA; HUMAN; INFORMED CONSENT; MAPLE SYRUP URINE DISEASE; MEDICAL ETHICS; MEDICAL SOCIETY; MEDIUM CHAIN ACYL COENZYME A DEHYDROGENASE DEFICIENCY; NEWBORN SCREENING; PEDIATRICIAN; PHENYLKETONURIA; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; REVIEW; SICKLE CELL ANEMIA; TANDEM MASS SPECTROMETRY; TOTAL PARENTERAL NUTRITION; TYROSINEMIA; UNITED STATES; DIFFERENTIAL DIAGNOSIS; DISEASE MANAGEMENT; GENETIC DISORDER; METHODOLOGY; NEWBORN; NEWBORN DISEASE; PEDIATRICS; PHYSICIAN ATTITUDE; PUBLIC HEALTH;

DNA;

DIAGNOSIS, DIFFERENTIAL; DISEASE MANAGEMENT; DNA; GENETIC DISEASES, INBORN; HUMANS; INFANT, NEWBORN; INFANT, NEWBORN, DISEASES; INFORMED CONSENT; NEONATAL SCREENING; PEDIATRICS; PHYSICIAN'S ROLE; PUBLIC HEALTH;

EID: 33749073859     PISSN: 00314005     EISSN: 02105721     Source Type: Journal    
DOI: 10.1542/peds.2006-1782     Document Type: Review

References (10)

1. Pass KA, Lane PA, Fernhoff PM, et al. US newborn screening system guidelines II: follow-up of children, diagnosis, management, and evaluation. Statement of the Council of Regional Networks for Genetic Services (CORN). J Pediatr. 2000;137:S1-S46
2. Larsson A, Therrell BL. Newborn screening: the role of the obstetrician. Clin Obstet Gynecol. 2002;45:697-710; discussion 730-732
3. American Academy of Pediatrics, Medical Home Initiatives for Children With Special Needs Project Advisory Committee. The medical home. Pediatrics. 2002;110:184-186
4. Serving the family from birth to the medical home. A report from the Newborn Screening Task Force convened in Washington DC, May 10-11, 1999. Pediatrics. 2000;106:2(2 pt 2):383-427
5. United States General Accounting Office. Newborn Screening: Characteristics of State Programs. Report to Congressional Requesters. Washington, DC: General Accounting Office; 2003. Publication No. GAO-03-449
6. Institute of Medicine, Committee on Assessing Genetic Risks. Assessing Genetic Risks: Implications for Health and Social Policy. Andrews LB, Fullarton JE, Holtzman NA, Motulsky AG, eds. Washington, DC: National Academy of Sciences; 1994
7. National Human Genome Research Institute. Promoting Safe and Effective Genetic Testing in the United States: Final Report of the Task Force on Genetic Testing. Holtzman NA, Watson MS, eds. Bethesda, MD: National Institutes of Health; 1997
8. Centers for Disease Control and Prevention. Using tandem mass spectrometry for metabolic disease screening among newborns: a report of a work group. MMWR Recomm Rep. 2001;50(RR-3):1-34
9. Schoen EJ, Baker JC, Colby CJ, To TT. Cost-benefit analysis of universal tandem mass spectrometry for newborn screening. Pediatrics. 2002;110:781-786
10. Nelson RM, Botkjin JR, Kodish ED, et al. Ethical issues with genetic testing in pediatrics. Pediatrics. 2001;107:1451-1455